JIN MEDICAL INTERNATIONAL LTD. Ordinary Shares Cash Flow Reinvestment Rate

Latest as of December 2025: 13.41x

JIN MEDICAL INTERNATIONAL LTD. Ordinary Shares cash flow reinvestment rate. JIN MEDICAL INTERNATIONAL LTD. Ordinary Shares (ZJYL) has a Cash Flow Reinvestment Rate of 13.41x as of December 2025, reinvesting $4.58 Million (capex $4.58 Million ) from operating cash flow of $341.55K. Explore ZJYL operating cash flow to total debt to assess how comfortably operating cash covers total debt obligations.

Reinvestment Rate

13.41x
(Capex + Investments) / Operating CF

Total Reinvested

$4.58 Million
Capex + Investments

Operating Cash Flow

$341.55K
USD

Capital Expenditures

$4.58 Million
USD

Cash Flow Reinvestment Rate of JIN MEDICAL INTERNATIONAL LTD. Ordinary Shares (2020–2025)

Cash flow reinvestment rate of JIN MEDICAL INTERNATIONAL LTD. Ordinary Shares from 2020 to 2025. Historical reinvestment intensity for JIN MEDICAL INTERNATIONAL LTD. Ordinary Shares across 5 annual periods. Explore ZJYL capital expenditure intensity to see what proportion of operating cash flow is directed to capital expenditures.

JIN MEDICAL INTERNATIONAL LTD. Ordinary Shares Cash Flow Reinvestment Rate by Year (2020–2025)

JIN MEDICAL INTERNATIONAL LTD. Ordinary Shares cash flow reinvestment rate by year from 2020 to 2025. Year-by-year capital reinvestment analysis for JIN MEDICAL INTERNATIONAL LTD. Ordinary Shares. For the full cash flow conversion analysis, see ZJYL cash generation efficiency.

Year Reinvestment Rate Total Reinvested (USD) Operating CF Capex YoY Change
2025 3.54x $10.29 Million $2.90 Million $6.63 Million ▲ +42.3%
2023 2.49x $7.74 Million $3.11 Million $113.94K ▲ +2345.3%
2022 0.10x $161.07K $1.58 Million $40.17K ▼ -46.4%
2021 0.19x $1.11 Million $5.84 Million $42.88K ▼ -77.4%
2020 0.84x $2.10 Million $2.50 Million $142.32K —
Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow